European CRO KCR, which operates across 18 countries in Europe as well as in the U.S., has recently registered new entities in the U.K. and Germany. This move is part of the company’s strategy to bring the business closer to Western European customers and deepen client relationships.
“I am very excited seeing KCR strengthening its visibility across Western Europe, particularly in the U.K. and Germany, where we have already been enjoying partnerships with locally based or represented companies,” said Mike Jagielski, CEO of KCR. “Having our own entities registered in these countries will make our collaboration even stronger. It also will equip KCR with local law benefits and make our business cooperation easier. The next country we aim for is France.”
KCR is well-established in Central and Eastern Europe (CEE) and the Commonwealth of Independent States (CIS), since 1997. The recent decision to open new entities in London and Berlin was part of its growth strategy to expand operations in Western Europe.
KCR offers three types of professional contract research services: clinical development services, functional service provision and post-marketing clinical services, in a wide spectrum of therapeutic areas.